Cargando…
12-Month clinical outcomes of amphilimus drug eluting stents in an all-comers South-East Asian registry
BACKGROUND: Amphilimus-eluting stent (AES) is a novel polymer-free drug eluting stent that combines sirolimus with fatty acid as antiproliferative drug and has shown promising results in percutaneous coronary intervention. We evaluated the clinical safety and efficacy of AES in an all-comers South-E...
Autores principales: | Ho, Hee Hwa, Sinaga, Dasdo Antonius, Arshad, Mohd Kamal Mohd, Kasim, Sazzli, Lee, Jin Hyun, Khoo, Deanna Zhi Lin, Loh, Kwok Kong, Jafary, Fahim Haider, Ong, Paul Jau Lueng, Lo, Simon Soo Siong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993003/ https://www.ncbi.nlm.nih.gov/pubmed/32021903 http://dx.doi.org/10.1016/j.ijcha.2020.100469 |
Ejemplares similares
-
Clinical Efficacy and Safety of SeQuent Please Paclitaxel-Eluting Balloon in a Real-World Single-Center Registry of South-East Asian Patients()()
por: Ho, Hee Hwa, et al.
Publicado: (2013) -
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial
por: Romaguera, Rafael, et al.
Publicado: (2021) -
Predictors of in-hospital mortality in patients with acute myocardial infarction complicated by cardiogenic shock in the contemporary era of primary percutaneous coronary intervention
por: Ho, Hee Hwa, et al.
Publicado: (2014) -
Causes of delay in door-to-balloon time in south-east Asian patients undergoing primary percutaneous coronary intervention
por: Sim, Wen Jun, et al.
Publicado: (2017) -
One‐year clinical outcomes of patients treated with polymer‐free amphilimus‐eluting stents or zotarolimus‐eluting stents: A propensity‐score adjusted analysis
por: Rozemeijer, Rik, et al.
Publicado: (2019)